Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
atopic dermatitis
Pharma
Dermavant CEO draws Botox comparison to instill Vtama confidence
Dermavant CEO Todd Zavodnick isn’t worried about the disappointing uptake of Vtama, saying it will flourish when it is approved for atopic dermatitis.
Kevin Dunleavy
Nov 28, 2023 4:10pm
With Dermavant's Vtama struggling, Leerink slashes projections
Nov 14, 2023 11:13am
Leo unveils detailed results on JAK cream win in hand eczema
Oct 13, 2023 11:05am
Incyte taps actor to help tell the stories of eczema patients
Oct 12, 2023 11:38am
Dermavant strengthens approval bid for Vtama in eczema
Oct 12, 2023 8:50am
Lilly suffers another FDA snub, this time for lebrikizumab
Oct 2, 2023 11:06am
